Interleukin-10 activates Toll-like receptor 4 and requires MyD88 for cardiomyocyte survival

Cytokine. 2013 Jan;61(1):304-14. doi: 10.1016/j.cyto.2012.10.013. Epub 2012 Nov 8.

Abstract

Toll-like receptors (TLRs) are important in a variety of inflammatory diseases including acute cardiac disorders. TLR4 innate signaling regulates the synthesis of anti-inflammatory cytokine, interleukin-10 (IL-10) upon TLR4 agonists' re-stimulation. Anti-apoptotic action of IL-10 in cardiac dysfunction is generally accepted but its protective mechanism through TLR4 is not yet understood. We studied the effect of IL-10 in the activation of TLR4 downstream signals leading to cardiomyocytes survival. IL-10 caused a significant increase in the expression of CD14, MyD88 and TLR4. TLR4 activation led to the translocation of the interferon regulatory factor 3 (IRF3) into the nucleus. Phosphorylation of IRF3 enhanced mRNA synthesis for IL-1β but not TNF-α and was elevated even after removal of IL-10 stimulation. Furthermore, degradation of inhibitory kappa B (IκB) kinase (Ikk) suggested that IκBβ was the main activating kinase for IRF3-regulated NF-κB activation and phosphorylation of p65. Phosphorylated NF-κB p65 was translocated into the nucleus. Concomitantly, an increase in Bcl-xL activity inhibited Bax and the proteolytic activity of caspase 3 as well as a decrease in PARP cleavage. An inhibition of MyD88, modulated the above listed responses to IL-10 as there was a decrease in TLR4 and IRF3 and an increase in TNF-α mRNA. This was associated with a decrease in NF-κB p65, Bcl-xL mRNA and protein levels as well as there was an activation of Bax and PARP cleavage independent of caspase 3 activation. These data in cardiomyocytes suggest that IL-10 induced anti-apoptotic signaling involves upregulation of TLR4 through MyD88 activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Caspase 3 / metabolism
  • Caspase Inhibitors
  • Cell Survival
  • Cells, Cultured
  • I-kappa B Kinase / metabolism
  • Interferon Regulatory Factor-3 / metabolism
  • Interleukin-10 / metabolism*
  • Interleukin-1beta / genetics
  • Lipopolysaccharide Receptors / biosynthesis
  • Male
  • Myeloid Differentiation Factor 88 / antagonists & inhibitors
  • Myeloid Differentiation Factor 88 / metabolism*
  • Myocytes, Cardiac / metabolism*
  • Phosphorylation
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases / metabolism
  • Protein Transport
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Toll-Like Receptor 4 / metabolism*
  • Transcription Factor RelA / metabolism
  • Tumor Necrosis Factor-alpha / genetics
  • bcl-2-Associated X Protein / antagonists & inhibitors
  • bcl-X Protein / metabolism

Substances

  • BCL2L1 protein, human
  • Caspase Inhibitors
  • IRF3 protein, human
  • Interferon Regulatory Factor-3
  • Interleukin-1beta
  • Lipopolysaccharide Receptors
  • MYD88 protein, human
  • Myeloid Differentiation Factor 88
  • RNA, Messenger
  • Toll-Like Receptor 4
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • bcl-2-Associated X Protein
  • bcl-X Protein
  • Interleukin-10
  • PARP1 protein, human
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases
  • I-kappa B Kinase
  • Caspase 3